Find out what’s new

EVALUATE THE APPLICATIONS AND POTENTIAL OF A TOMOSYNTHESIS SYSTEM TO SUPPORT CLINICIANS IN DIAGNOSIS OF CHEST AND LUNG DISEASES

AI Empowering Early Detection of CAD Patients for Improved Cardiac Care

Findings presented at SCCT 2024

Optimizing Preventive Cardiology: Harnessing AI for Early Detection of Coronary Artery Disease

Findings presented at SCCT 2024

Artificial Intelligence in Medical Imaging: An Overview of a Decade of Experience

Medical imaging data has been at the frontier of artificial intelligence innovation in medicine with many clinical applications.

Evaluation Of The Diagnostic Potential Of A Novel Tomosynthesis System For MSK

Digital tomosynthesis (DTS) is a well-established technology that has become the gold standard for breast mammography. In recent years its benefits in musculoskeletal (MSK) imaging have been acknowledged and lead to a rapid increase in its utilization.

Evaluation Of The Diagnostic Potential Of A Novel Tomosynthesis System For Chest And Lung Diseases

Chest Digital Tomosynthesis (DTS) is known for its capability to overcome significant chest radiographs limitations (CXR). It improves detection of chest lesions and their anatomic localization and can exclude false lesions.

Digital Tomosynthesis Applications and the NANO-X Solution

Digital Tomosynthesis (DTS) is a well-established technique for producing slice images using x-ray systems. It is a refinement of conventional geometric tomography, which was developed in the 1930’s by the Italian radiologist Alessandro Vallebona.

Validation of HealthOST by Nanox.AI

image processing software that provides qualitative and quantitative analysis of the spine from CT images to support clinicians in the evaluation and assessment of musculoskeletal disease of the spine

Assessment of Coronary Artery Calcification on Non-Gated Conventional CT Scans Using Artificial Intelligence Integraion

Opportunistic Screening of Coronary Artery Calcification on Non-gated Conventional CT scans Using Artificial Intelligence

Findings presented at SCCT 2024

A recent study suggests high clinical and economic efficacy for opportunistic screening using the AI tools. Nanox.AI solutions can enable and simplify cost savings by helping detect and report opportunistic findings related to chronic diseases

To assess the cost-effectiveness and clinical efficacy of AI-assisted abdominal CT-based opportunistic screening for atherosclerotic cardiovascular (CV) disease, osteoporosis, and sarcopenia using artificial intelligence (AI) body composition algorithms.

Real-world performance of AI enabled vertebral fracture (VF) algorithm for fracture liaison studies: The ADOPT Study

Fewer than 30% of vertebral fragility fractures (VFs) are reported on routine clinical CT scans by radiologists